Dan Wang

机构：Tianjin Medical University General Hospital · ORCID：0000-0003-0526-8711

发表论文 29 篇 · 总被引 429 次 · h-index 13

代表论文

• Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway (2018 · Mediators of Inflammation · 被引 46)
• Resveratrol Inhibited Non–small Cell Lung Cancer Through Inhibiting STAT-3 Signaling (2016 · The American Journal of the Medical Sciences · 被引 44)
• LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer (2016 · Scientific Reports · 被引 41)
• Endovascular Treatment for Acute Thromboembolic Occlusion of the Superior Mesenteric Artery and the Outcome Comparison between Endovascular and Open Surgical Treatments: A Retrospective Study (2017 · BioMed Research International · 被引 40)
• Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma (2017 · Scientific Reports · 被引 32)
• Exposure to Cigarette Smoke Augments Post-ischemic Brain Injury and Inflammation via Mobilization of Neutrophils and Monocytes (2019 · Frontiers in Immunology · 被引 24)